Advanced HIV: Outcomes for Rapid ART
Condition:   HIV-1-infection Intervention:   Drug: Bictegravir/emtricitabine/tenofovir alafenamide Sponsors:   Valley AIDS Council;   Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2022 Category: Research Source Type: clinical trials

Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Conditions:   HIV Infection Primary;   Hepatitis, Viral, Human;   Sexually Transmitted Infections, Excluding HIV and Hepatitis Intervention:   Drug: Tenofovir Disoproxil Fumarate 300 MG Oral Tablet Sponsors:   Hospitales Universitarios Virgen del Rocío;   Instituto de Biomedicina de Sevilla Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2022 Category: Research Source Type: clinical trials